INTERPACE BIOSCIENCES, INC. Net Change in Cash
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Net Change in Cash of $183.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-10
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $142.00K.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$265.00K.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$686.00K, a 189.32% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $768.00K.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $1.04M.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$2.04M.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$1.33M, a 187.85% decline from fiscal 2022.
- INTERPACE BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $1.51M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $183.00K 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | $142.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $1.04M 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$38.00K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | -$959.00K 10-Q · filed 2026-08-10 | |||
| 2025-03-31 | -$265.00K 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | -$2.04M 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$1.39M 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$1.48M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$686.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$1.33M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $204.00K 10-K · filed 2025-03-31 | |||
| 2023-06-30 | $251.00K 10-K · filed 2025-03-31 | |||
| 2023-03-31 | $768.00K 10-K · filed 2025-03-31 | |||
| 2022-12-31 | $1.51M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $3.00M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$1.20M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$214.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | -$58.00K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $58.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $669.00K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $67.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $1.05M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $2.99M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $12.79M 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $11.05M 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | -$3.75M 10-K · filed 2021-04-01 | |||
| 2019-09-30 | -$3.71M 10-Q · filed 2021-01-20 | |||
| 2019-06-30 | -$1.86M 10-Q/A · filed 2021-01-19 | |||
| 2019-03-31 | $3.06M 10-Q/A · filed 2021-01-19 | |||
| 2018-12-31 | -$9.13M 10-K/A · filed 2021-01-19 | |||
| 2018-09-30 | -$7.20M 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | -$5.12M 10-Q · filed 2019-08-13 |